Abstract
Bacterial efflux pumps that transport antibacterial drugs out of the bacterial cells have broad specificity, commonly leading to broad spectrum resistance and limiting treatment strategies for infections. It remains unclear how efflux pumps can maintain this broad spectrum specificity to diverse drug molecules while limiting the efflux of other cytoplasmic content. We investigate the origins of this broad specificity using theoretical models informed by the experimentally determined structural and kinetic properties of efflux pumps. We develop a set of mathematical models describing operation of efflux pumps as a discrete cyclic stochastic process across a network of states characterizing pump conformations and the presence/absence of bound ligands and protons. We find that the pump specificity is determined not solely by the drug affinity to the pump—as is commonly assumed—but it is also directly affected by the periplasmic pH and the transmembrane potential. Therefore, the pump effectiveness in removing a particular drug molecule from the cell can be tuned by modifying the proton concentration gradient and the voltage drop across the membrane. Furthermore, we find that while both the proton concentration gradient across the membrane and the transmembrane potential contribute to the thermodynamic force driving the pump, their effects on the efflux enter not strictly in a combined proton motive force, but rather they have two distinguishable effects on the overall throughput. These results potentially explain the broad specificity of efflux pumps and suggest ways to overcome bacterial resistance, while highlighting unexpected effects of thermodynamic driving forces out of equilibrium.
Introduction
Bacterial multidrug resistance is a global health crisis, largely driven by efflux pumps—molecular machines that vacuum antibiotics out of the cell. A long-standing puzzle in microbiology is how these pumps maintain "broad specificity" (the ability to pump many different drugs) while remaining selective enough not to accidentally deplete the cell of essential nutrients.
Traditionally, researchers have assumed that specificity is a static property dictated by the physical binding affinity ($K_D$) between the drug and the pump. Furthermore, it is generally assumed that the "Proton Motive Force" (PMF)—the energy source for these pumps—acts as a single, combined thermodynamic push. This study challenges these views, investigating whether the individual components of the PMF (the pH gradient and the electrical voltage) play distinct, active roles in tuning which drugs get pumped and how efficiently.
Modeling Efflux as a Stochastic Process
The authors developed two mathematical models to describe the pump as a discrete cyclic stochastic process (a Markov jump process). The primary model is a three-state minimal cycle consisting of: (1) an empty pump, (2) a drug-bound state, and (3) a drug-and-proton-bound state. This simplification allows for exact analytical solutions to explore how environmental variables interact. A more detailed five-state model was also used to verify these insights by deconstructing conformational changes and ligand release into separate steps.
The models utilize Master Equations to calculate the steady-state efflux rate ($J$), using physically realistic parameters derived from literature on RND-family pumps like AcrAB-TolC in E. coli. Transition rates and interaction volumes were calibrated to match experimentally determined structural and kinetic properties.
Key Insights: Dynamic Specificity and PMF Decoupling
A central finding is that pump specificity is dynamic rather than static. The "effective affinity" ($K_M$) of the pump is not merely the chemical binding constant ($K_D$), but a complex function of the environment. This implies that a pump can be "tuned" to be more or less specific to a certain drug without structural mutations.
Crucially, the study reveals that transmembrane voltage and the pH gradient do not affect the pump identically. While both contribute to the total driving force, they enter the kinetic equations at different stages, resulting in distinguishable effects on overall throughput. This decoupling allows for a "peak-shifting" effect: increasing the proton concentration in the periplasm (lowering pH) shifts the peak efflux rate toward weaker-binding drugs.
Results: Tunability and Non-Equilibrium Advantage
The models demonstrate that active efflux pumps achieve a higher degree of specificity than passive channels by operating far from thermodynamic equilibrium. The efflux rate $J$ follows a Michaelis-Menten-like dependence on drug concentration, but the parameters are modulated by the proton gradient.
In both models, varying the periplasmic pH from 7 to 5 shifted the optimal drug dissociation constant ($K_D$) by a factor of 5 to 6. This suggests that bacteria might physiologically adjust their internal/external pH or membrane potential to "re-tune" their pumps for specific antibiotics, providing a novel mechanism for adaptation to antibiotic exposure.
Discussion and Future Directions
While these minimal models provide significant insights, they are abstractions of complex trimeric pumps like AcrB, which may have additional kinetic constraints. Future work should focus on experimental validation in live bacterial cultures to test if shifting pH indeed shifts the optimal $K_D$ for drug extrusion. Additionally, optimization algorithms could be employed to explore the theoretical limits of pump specificity and tunability across a broader parameter space, potentially identifying new targets for overcoming bacterial resistance.
Summary updated